Edition:
United States

Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

27.58USD
20 Jan 2017
Change (% chg)

$0.35 (+1.29%)
Prev Close
$27.23
Open
$27.26
Day's High
$27.64
Day's Low
$27.04
Volume
56,286
Avg. Vol
67,805
52-wk High
$33.94
52-wk Low
$22.02

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.04 December 20 Jan 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 1 2 2 2
(3) HOLD 6 4 4 4
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.46 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 9 88.13 93.00 85.10 89.75
Quarter Ending Jun-17 9 89.72 92.00 87.77 91.39
Year Ending Dec-17 13 363.30 377.00 347.00 372.36
Earnings (per share)
Quarter Ending Mar-17 11 -0.04 0.06 -0.12 0.02
Quarter Ending Jun-17 11 -0.00 0.06 -0.07 0.02
Year Ending Dec-17 13 0.06 0.45 -0.37 0.29

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 83.24 82.26 0.98 1.17
Quarter Ending Jun-16 81.27 81.97 0.70 0.86
Quarter Ending Mar-16 78.12 80.89 2.77 3.55
Quarter Ending Sep-15 73.12 73.55 0.43 0.59
Quarter Ending Jun-15 71.65 70.62 1.03 1.44

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 88.13 88.14 88.39 88.33 89.75
Quarter Ending Jun-17 89.72 89.84 89.86 89.56 91.39
Year Ending Dec-17 363.30 363.66 363.49 362.87 372.36

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 1 0 1 1
Quarter Ending Jun-17 1 0 1 1
Year Ending Dec-17 1 0 2 0
Earnings